Skip to main content

Rapid Implementation of NAT technology for Mycoplasma with AnaBioTec & BIOFIRE® Mycoplasma

Rapid Implementation of NAT technology for Mycoplasma with AnaBioTec & BIOFIRE Mycoplasma

Join us for a free webinar co-hosted by bioMérieux and our partners, AnaBioTec. In this insightful webinar, you'll learn how rapid Nucleic Acid Amplification Techniques (NAATs), such as BIOFIRE ® Mycoplasma, can be seamlessly implemented as an alternative method for Mycoplasma detection in pharmaceutical production. By attending this webinar you will:

✅ Learn how bioMérieux's BIOFIRE ® Mycoplasma NAAT-based PCR solution can reduce your product release time from 28 days to 1 hour

✅ Understand how AnaBioTec can help you create fast, reproducible and sensitive results for in-process control and product release testing

✅ Gain knowledge on method qualification, validation and transfer for Mycoplasma testing

✅ Learn how bioMérieux and AnaBioTec are working together to help on your alternative method validation process for Mycoplasma testing has context menu

 

Watch the replay

Access to the replay

 

 

Want to know more?

Please accept targeting cookies to allow content

Related Products

BIOFIRE® Mycoplasma

BIOFIRE® Mycoplasma provides simple, accurate, and rapid in-house mycoplasma detection for use in testing raw materials, in-process samples, and final product release. We offer validation services designed to meet regulatory requirements—from documentation to comprehensive on-site support.

Read More